KUALA LUMPUR: Covid-19 patients who took Ivermectin were more likely to get diarrhoea, says Datuk Dr Noor Azmi Ghazali.
The Deputy Health Minister I said the ministry's clinical trials concluded that other than giving patients an upset stomach, there were no significant differences between those given Ivermectin and those treated using Covid-19 standard care treatment.
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

